Hospira 4Q Revenues: $913.7 million (-3%) 4Q Earnings: $155.7 million (+37%) FY Revenues: $3.6 billion (+6%) FY Earnings: $517.8 million (+71%) Comments: In the Americas Pharmaceutical Specialty Injectables sales were $347.2 million in the quarter (-1%) and $1.3 billion for the year (+7%). Other Pharma revenue was $147.6 million in the quarter (-5%) and $522 million for the year (-5%). Devices Medication Management Systems revenue was $140.6 million (+9%) and $558.9 million for th...